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it is crucial to better understand the processes that direct the for- 
mation of a functional collagen network in cartilage. The present 
study was designed to test whether initial blockage of collagen 
crosslinking would stimulate collagen synthesis and whether sub- 
sequent formation of the crosslinks would result in a functional 
collagen network. 
Methods: Bovine articular chondrocytes were cultured in alginate 
beads for 5 weeks in the presence or absence of the lysyl oxidase 
inhibitor BAPN (0.1 mM, 0.25mM or 0.5mM) followed by 5 weeks 
without BAPN. Proteoglycan synthesis (colorimetric assay), colla- 
gen synthesis and amout of crosslinks were measured biochem- 
ically (HPLC) at several timepoints. 
Results: Inhibition of lysyl oxidase with BAPN caused an in- 
crease in total collagen levels. As from week 5, there was ap- 
proximately 1.5 times more collagen deposition in cultures sup- 
plemented with BAPN than in the control condition, reaching 
1.84 times more after 10 weeks (8.9 I~g collagen/bead vs. 16.4 
i~g/bead). There was no difference in the proteoglycan deposi- 
tion. Until week 6 there was a low amount of crosslinks in the 
collagen detectable in the matrix produced by chondrocytes in 
the presence of BAPN (0.18 pmol HP/pmol collagen) whereas 
collagen deposited without the presence of BAPN had a higher 
level of crosslinking (0.53 pmol HP/pmol collagen). From week 8 
on, 3 weeks after removal of BAPN, the amount of crosslinks in 
all three conditions approached the level of the control condition 
(0.70 HP/collagen in the control condition vs. 0.60 HP/collagen 
with BAPN) in week 10. No dosis effect was observed for BAPN. 
Conclusion: Blockage of collagen crosslinking with BAPN at first 
stimulates collagen synthesis compared to the control condition, 
followed by the formation of an equal amount of crosslinks after 
removal of the lysyl oxidase inhibitor. The effect of more colla- 
gen with the same amount of crosslinks per collagen molecule 
on mechanical properties requires further investigation. 
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The goal of this study is to demonstrate the role of the subchon- 
dral bone in the development and progression of hyaline cartilage 
degeneration in the knee joint. 
We utilized a murine model of Osteogenesis Imperfecta (OI) to 
determine whether abnormalities in bone predispose the joint to 
the development of osteoarthritis. 
OI is a genetic disease of humans that is caused by a mutation in 
type I collagen and is expressed in bone and ligament, but not in 
hyaline articular cartilage. The animals employed were a knock-in 
model of type IV OI and age matched wild-type (WT) controls. 
High resolution micro-computed tomography (micro-CT) and 
micro-magnetic resonance imaging (micro-MRI) with gadolinium 
contrast enhancement, as well as histologic evaluation, were em- 
ployed to study the knee joints of a pair of OI and a pair of WT 
animals age 2, 4, 6, and 12 months and one animal each at 22 
months. 
The results document for the first time that OI mice develop 
rapidly progressive OA. Micro-CT and micro-MRI documented 
age-related joint space narrowing, extra-articular ossification, and 
progressive subchondral bone thickening and cyst formation in 
the OI mice. Histologic examination showed typical aggressive 
cartilage destruction with osteophyte formation in the OI mice. 
These results clearly demonstrate that abnormalities in subchon- 
dral bone can lead to rapidly progressive OA in the absence of 
intrinsic cartilage abnormalities. 
Moreover, the data suggest that OI mice might serve as a useful 
model of OA that can be employed to examine the pathophysiol- 
ogy of cartilage damage as well as the impact of therapies. 
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Objective: Both matrix metalloprotease (MMP) activity and 
cathepsin K activity have been implicated in cartilage turnover. 
We investigated the relative contribution of MMP activity and 
cathepsin K activity in cartilage degradation usingex vivo and in 
vivo models. 
Methods: Bovine articular cartilage explants were cultured in 
presence of oncostatin M (OSM) 10 ng/ml, tumor necrosis 
factor-a (TNF-~) 20 ng/ml in the presence or absence of the 
broad-spectrum MMP activity inhibitor GM6001 and the cys- 
teine protease inhibitor E64. Cartilage degradation was evalu- 
ated in the conditioned medium by measurement of crosslinked 
C-telopeptide fragments of type II collagen (CTX-II) and gly- 
cosaminoglycans (GAG), which were compared to immunohisto- 
chemical evaluations of proteoglycans and CTX-II. We assessed 
MMP expression by gelatine zymography and cathepsin K ex- 
pression by immunohistochemistry. 
Results: OSM and TNF-~ in combination induced a 500-fold in- 
crease in cartilage degradation products measured by CTX-II 
(P<0.001) compared to vehicle control. The growth factors po- 
tently induced MMP expression, assessed by zymography, and 
cathepsin K expression investigated by immunohistochemistry. 
Inhibition of MMP activity by GM6001 completely abrogated CTX- 
II release (P<0.001) and inhibited proteoglycan release by 72% 
(p<0.001). In contrast, E64 resulted in an increased CTX-II re- 
lease by 100% (P<0.05) and inhibited GAG release by 33% 
(p<0.01). An up-regulation of CTX-II fragments was confirmed 
in vivo in cathepsin K null mice. 
Conclusions: Inhibition of MMP activity reduced both proteo- 
glycan-loss and type II collagen degradation. In contrast, inhibi- 
tion of cysteine proteases resulted in an increase rather than a 
decrease in collagen type II degradation, suggesting compensa- 
tion by other proteases. 
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Aim of study: In this study we investigated if the inhibition of 
MRC is able to modulate the inflammatory response in human 
OA chondrocytes. 
Methods: Human OA chondrocytes were isolated from cartilage 
obtained from the femoral heads of patients undergoing joint re- 
placement surgery. Rotenone, 3-nitropropionic acid (NPA), an- 
timycin A, sodium azide and oligomycin were employed to in- 
hibit complex I, II, III, IV or V of CRM, respectively. LPS was em- 
ployed as positive control. Cell viability was evaluated using the 
